Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The antineoplastic properties of FTY720: Evidence for the repurposing of fingolimod.
Using mental visual imagery to improve autobiographical memory and episodic future thinking in relapsing-remitting multiple sclerosis patients: A randomised-controlled trial study.
Impaired growth of the cerebellum in pediatric-onset acquired CNS demyelinating disease.
In silico investigation of novel biological pathways: The role of CD200 in regulation of T cell priming in experimental autoimmune encephalomyelitis.
A computer-based screening method for distress in patients with multiple sclerosis: a feasibility study.
A pilot study examining functional brain activity 6 months after memory retraining in MS: the MEMREHAB trial.
Association between OSA and Severe Fatigue in Patients with Multiple Sclerosis (MS).
The Impact of Methylprednisolone Pulses during Relapses of Multiple Sclerosis on the Kinetics of Anti-Interferon-Beta Antibodies.
Abnormal galactosylation of immunoglobulin G in cerebrospinal fluid of multiple sclerosis patients.
Neuromyelitis optica does not impact periventricular venous density versus healthy controls: a 7.0 Tesla MRI clinical study.
Self-report assessment of fatigue in multiple sclerosis: a critical evaluation.
Novel therapeutic options for multiple sclerosis.
Adherence and Persistence among Patients Treated with First-Line Therapies for Relapsing-Remitting Multiple Sclerosis in Brazil.
A placebo controlled trial for an NMO relapse prevention treatment: Ethical considerations.
Detection of demyelination in multiple sclerosis by analysis of [Formula: see text] relaxation at 7 T.
B Cells Fuel Inflammation in Multiple Sclerosis.
Chronic stress regulates NG2(+) cell maturation and myelination in the prefrontal cortex through induction of death receptor 6.
The Plant-Derived Chalcone 2,2',5'-Trihydroxychalcone Provides Neuroprotection against Toll-Like Receptor 4 Triggered Inflammation in Microglia.
Current and Emerging Therapies for Multiple Sclerosis.
1,25-Dihydroxyvitamin D3 impairs the differentiation of effector memory T cells in vitro in multiple sclerosis patients and healthy controls.
Disease exacerbation after rituximab induction in neuromyelitis optica.
Association between perceived fatigue and gait parameters measured by an instrumented treadmill in people with multiple sclerosis: a cross-sectional study.
The Clinical Significance of the Neutrophil-to-Lymphocyte Ratio in Multiple Sclerosis.
Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients.
Symptoms of multiple sclerosis during use of combined hormonal contraception.
Pages
« first
‹ previous
…
626
627
628
629
630
631
632
633
634
…
next ›
last »